Split-virion intranasal vaccine (Archimedes Pharma)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSplit-virion intranasal vaccine (Archimedes Pharma)
Drug Alias Name裂解病毒粒子鼻内疫苗-Archimedes development limitedNASPANVAC
ClassificationVaccines > Development/production technology > Inactivated vaccine > Split vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsInfluenza in Birds
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesArchimedes
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArchimedes
Active IndicationsN/A
Inactive IndicationsInfluenza in Birds

Other Information

ATC CodeN/A
Related LinksN/A